CA

Jamie Mann

This inventor holds 3 USPTO granted patents. Top assignee: Case Western Reserve University. Active years: 2020-2025.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jamie Mann: Innovator in HIV Treatment

Introduction

Jamie Mann is a prominent inventor based in California, known for her significant contributions to the field of HIV treatment. With a total of 3 patents, she has focused her research on innovative methods to combat latent HIV-1 infections.

Latest Patents

One of her latest patents is titled "Autologous and Allogenic HIV-1 Proteins for the Treatment of Latent HIV-1 Infection." This patent describes a method of reducing a latent HIV-specific memory-CD4+ T cell pool in a subject. The method includes administering at least one HIV-1 protein derived from an allogenic infecting HIV-1 virus, along with a pharmaceutically acceptable carrier. The HIV-1 protein stimulates latent HIV-specific memory CD4+ T cells to induce latent HIV-1 replication, resulting in the death of HIV-specific memory-CD4+ T cells in the subject.

Career Highlights

Jamie Mann is affiliated with Case Western Reserve University, where she continues her research and development in the field of HIV treatment. Her work has garnered attention for its potential to change the landscape of HIV therapies.

Collaborations

Some of her notable coworkers include Eric J Arts, who has collaborated with her on various research projects.

Conclusion

Jamie Mann's innovative work in HIV treatment showcases her dedication to advancing medical science. Her patents reflect her commitment to finding effective solutions for latent HIV-1 infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…